Thanks!<Unsubtracted.png><Subtracted.png>--
You received this message because you are subscribed to the Google Groups "BioXTAS RAW" group.
To unsubscribe from this group and stop receiving emails from it, send an email to bioxtas_raw...@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/bioxtas_raw/7e5326cd-d5ff-4107-81d8-c79ac897ca11n%40googlegroups.com.
<Subtracted.png><Unsubtracted.png>
Based on MALS, the main peak has a MW of 275 kDa (screenshot attached). I am interested in the first peak. I suspect the 2nd one is degradation.
Thanks!
Xiaolan
On Aug 13, 2025, at 2:50 PM, XiaoLan Yao <yao...@umsystem.edu> wrote:
Hi Jesse,Thank you very much for the detailed reply. This is very helpful. To answer your question, we collected SEC-SAXS-MALS-DLS data at APS with a Wyatt 030S5 300Å column years ago. Based on the frame number of the first peak vs the last frame number (303/966, ~ 31%), it does look like the first peak is at the void volume. This protein is predicted to have a large disordered region and an elongated shape, I wonder if these factors contributed to the early elution volume? We only used GE SD200 column in our lab, it always elutes off after the void, so maybe a different column at APS would have worked better? Based on the SEC-MALS data, the elution volume at the center of the Rayleigh Ratio peak is 7.4 ml out of 20.6 ml column volume, which is ~ 36%. I wonder if the difference of peak volume between the MALS vs SAXS measurements is yet another indication of heterogeneity? There is also a 2nd peak in the SEC-MAS data, but at a much later elution volume compared to the SEC-SAXS data (screenshot attached).
Based on MALS, the main peak has a MW of 275 kDa (screenshot attached). I am interested in the first peak. I suspect the 2nd one is degradation.
Thanks!
Xiaolan
<SEC-MALS.png><MW.png>
To view this discussion visit https://groups.google.com/d/msgid/bioxtas_raw/4de6f42c-e864-4c10-9197-66936850ae08n%40googlegroups.com.
<SEC-MALS.png><MW.png>